LOX and neoplasm: Together, our in vitro and in vivo data demonstrate that PXS-5505 inhibition of lysyl oxidase family-mediated collagen crosslinking combined with chemotherapy reduces tumor desmoplasia, decreases local invasion through a collagen-rich environment and reduces metastasis in vivo.